IL78929D0 - Microemulsion compositions for parenteral administration - Google Patents

Microemulsion compositions for parenteral administration


Publication number
IL78929D0 IL7892986A IL7892986A IL78929D0 IL 78929 D0 IL78929 D0 IL 78929D0 IL 7892986 A IL7892986 A IL 7892986A IL 7892986 A IL7892986 A IL 7892986A IL 78929 D0 IL78929 D0 IL 78929D0
Prior art keywords
parenteral administration
microemulsion compositions
Prior art date
Application number
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US75979685A priority Critical
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL78929D0 publication Critical patent/IL78929D0/en


IL7892986A 1985-07-29 1986-05-27 Microemulsion compositions for parenteral administration IL78929D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US75979685A true 1985-07-29 1985-07-29

Publications (1)

Publication Number Publication Date
IL78929D0 true IL78929D0 (en) 1986-09-30



Family Applications (1)

Application Number Title Priority Date Filing Date
IL7892986A IL78929D0 (en) 1985-07-29 1986-05-27 Microemulsion compositions for parenteral administration

Country Status (9)

Country Link
EP (1) EP0211258A3 (en)
JP (1) JPS6229511A (en)
KR (1) KR900003557B1 (en)
AU (1) AU589430B2 (en)
DK (1) DK354886A (en)
ES (1) ES8708185A1 (en)
GR (1) GR861462B (en)
IL (1) IL78929D0 (en)
ZA (1) ZA8604031B (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
GB8714652D0 (en) * 1987-06-23 1987-07-29 Davis S S Drug emulsion
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
JP2600726B2 (en) * 1987-11-30 1997-04-16 大正製薬株式会社 Fine fat emulsion
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (en) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
DE68914929T2 (en) * 1988-09-29 1994-08-11 Shiseido Co Ltd Emulsified composition.
GB8828517D0 (en) * 1988-12-07 1989-01-11 Leopold & Co Ag Stable emulsions
JP2653245B2 (en) * 1989-11-27 1997-09-17 日本新薬株式会社 Fat emulsion
DE69027941T2 (en) * 1989-11-27 1997-01-23 Nippon Shinyaku Co Ltd fat emulsion
TW211015B (en) * 1990-01-11 1993-08-11 Nippon Shinyaku Co Ltd
DE4015108A1 (en) * 1990-05-11 1991-11-14 Leopold Pharma Gmbh Stable emulsion for administration of pharmacologically active ingredients
IT1243193B (en) * 1990-08-10 1994-05-24 Medea Res Srl oral pharmaceutical compositions based on melatonin
TW203010B (en) * 1990-10-31 1993-04-01 Otsuka Pharma Co Ltd
DE69133042D1 (en) * 1990-11-06 2002-07-25 Nippon Shinyaku Co Ltd Lyophilized preparation as well as their production
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
JPH0672890A (en) * 1992-06-26 1994-03-15 Nippon Kayaku Co Ltd Emulsion preparation of aureobasidin
DK0589843T3 (en) 1992-09-25 2002-04-02 Novartis Ag Cyclosporin-containing pharmaceutical preparations
DE4234225A1 (en) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stable topical formulations with good drug release property containing at least one macrolide antibiotic lipophilized
US5969004A (en) * 1993-10-15 1999-10-19 The Gillette Company Aqueous inks
AU682580B2 (en) * 1994-02-25 1997-10-09 Takeda Chemical Industries Ltd. Injectable emulsions containing antifungal triazole derivatives
AU715165B2 (en) 1994-11-03 2000-01-20 Novartis Ag Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
SE9503143D0 (en) 1995-09-12 1995-09-12 Astra Ab New preparation
DE19549852B4 (en) 1995-11-29 2009-06-04 Novartis Ag The cyclosporin-containing preparations
KR20040004416A (en) 1997-01-30 2004-01-13 노파르티스 아게 Oil-Free Pharmaceutical Compositions Containing Cyclosporin A
DE69929128T2 (en) 1998-08-31 2006-06-29 Nipro Corp. Nutrient infusion preparation
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB2350297A (en) * 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
UA95238C2 (en) 2005-06-27 2011-07-25 Ґлаксосмітклайн Байолоджікалз С.А. Immunogenic composition
WO2008102065A1 (en) * 2007-02-14 2008-08-28 Commissariat A L'energie Atomique Fluorescent emulsions for optical imaging
FR2934953B1 (en) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions nanocrystals
FR2934955B1 (en) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation of lipophilic or amphiphilic therapeutic agents in nanoemulsions
FR2934954B1 (en) 2008-08-14 2011-07-22 Commissariat Energie Atomique Fluorescent emulsion of indocyanine green
CN101461782B (en) 2008-12-16 2011-07-06 海南美大制药有限公司 Sub-microemulsion preparation for levocarnitine injection and preparation method thereof
WO2011149412A1 (en) * 2010-05-13 2011-12-01 Astrazeneca Ab Injectable emulsion of sedative hypnotic agent
AU2011340797B2 (en) * 2010-12-10 2017-08-10 Ns Technologies Pty Ltd Methods for forming miniemulsions and use thereof for delivering bioactive agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS537492B2 (en) * 1973-02-12 1978-03-18
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
JPS6030652B2 (en) * 1979-05-07 1985-07-17 Green Cross Corp
JPS5924132B2 (en) * 1980-12-02 1984-06-07 Hayashibara Seibutsu Kagaku Kenkyusho Kk
JPH0463049B2 (en) * 1983-04-20 1992-10-08 Ajinomoto Kk
JPH0647533B2 (en) * 1984-08-10 1994-06-22 日本レダリー株式会社 4- biphenylyl acetic compound containing fat emulsion
IL78930D0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration

Also Published As

Publication number Publication date
EP0211258A2 (en) 1987-02-25
ZA8604031B (en) 1987-01-28
ES556056A0 (en) 1987-10-01
DK354886D0 (en) 1986-07-25
ES8708185A1 (en) 1987-10-01
ES556056D0 (en)
KR900003557B1 (en) 1990-05-21
DK354886A (en) 1987-01-30
JPS6229511A (en) 1987-02-07
AU6021486A (en) 1987-02-05
GR861462B (en) 1986-10-02
EP0211258A3 (en) 1987-11-19
AU589430B2 (en) 1989-10-12

Similar Documents

Publication Publication Date Title
GB2199829B (en) Peptide derivatives
EG19550A (en) Shampo compositions
EG19470A (en) Shampo compositions
AR243591A1 (en) Fuel compositions
AU589430B2 (en) Microemulsion compositions
GR862727B (en) Pharmaceutical preparation
LTIP1680A (en) Pharmaceutical preparation
SG107292G (en) Pharmaceutical compositions having good stability
ZW1486A1 (en) Peptide derivatives
JPS62181280A (en) Trichothecin conjugate
IE59515B1 (en) Pharmaceutical composition
GB8617652D0 (en) Acylanilide derivatives
ZA8607318B (en) Pharmaceutical composition
IE873449L (en) 3-aryloxypropanamine derivatives
GB8518979D0 (en) Pharmaceutical preparation
ZA8703583B (en) Imidazoquinolinylether derivatives
EP0335545A3 (en) Pharmaceutical formulations for parenteral use
ZA8703962B (en) 5-acylamino-pyrazole derivatives
GB8601915D0 (en) Pharmaceutical compositions
GB8724890D0 (en) Pharmaceutical compositions
JPS61226049A (en) Administration package
ZA8603132B (en) 8-phenylxanthine derivatives
PH22428A (en) N-phenylpyridone derivatives
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8602787D0 (en) Pharmaceutical composition